Mack Gene
SEC CIK 1737979 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GANX | Gain Therapeutics, Inc. | CFO, Interim CEO | 14.4K | $14.5K | — | 1 | 2024-08-09 | 2024-08-09 |
Most active insiders at GANX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| No open-market trades in the last year. | ||||
Mack Gene made no open-market trades at GANX in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-12 | 2024-08-09 | GANX | Gain Therapeutics, Inc. | Mack Gene | CFO, Interim CEO | P - Purchase | $1.01 | +14.4K | 14.4K | New | +$14.5K |
Purchase Sale Sale after option exercise All abbreviations